COVID-19 and QT interval prolongation: more than just drug toxicity?

MeSH terms

• Adrenergic beta-Agonists / administration & dosage
• Aged
• Anti-Infective Agents / administration & dosage
• Anti-Infective Agents / adverse effects
• Azithromycin* / administration & dosage
• Azithromycin* / adverse effects
• Betacoronavirus / isolation & purification
• COVID-19
• COVID-19 Testing
• Clinical Laboratory Techniques
• Coronavirus Infections* / blood
• Coronavirus Infections* / diagnosis
• Coronavirus Infections* / physiopathology
• Coronavirus Infections* / therapy
• Electrocardiography / methods
• Humans
• Hydroxychloroquine* / administration & dosage
• Hydroxychloroquine* / adverse effects
• Isoproterenol / administration & dosage
• Long QT Syndrome* / blood
• Long QT Syndrome* / diagnosis
• Long QT Syndrome* / drug therapy
• Long QT Syndrome* / etiology
• Male
• Myocarditis* / blood
• Myocarditis* / complications
• Myocarditis* / virology
• Pandemics*
• Pneumonia, Viral* / blood
• Pneumonia, Viral* / diagnosis
• Pneumonia, Viral* / etiology
• Pneumonia, Viral* / physiopathology
• Pneumonia, Viral* / therapy
• SARS-CoV-2
• Treatment Outcome
• Troponin I / blood*